(Press-News.org) A drug that works through the same brain mechanism as the fast-acting antidepressant ketamine briefly improved treatment-resistant patients' depression symptoms in minutes, with minimal untoward side effects, in a clinical trial conducted by the National Institutes of Health. The experimental agent, called AZD6765, acts through the brain's glutamate chemical messenger system.
Existing antidepressants available through prescription, which work through the brain's serotonin system, take a few weeks to work, imperiling severely depressed patients, who can be at high risk for suicide. Ketamine also works in hours, but its usefulness is limited by its potential for dissociative side-effects, including hallucinations. It is being studied mostly for clues to how it works.
"Our findings serve as a proof of concept that we can tap into an important component of the glutamate pathway to develop a new generation of safe, rapid-acting practical treatments for depression," said Carlos Zarate, M.D., of the NIH's National Institute of Mental Health, which conducted the research.
Zarate, and colleagues, reported on their results online Dec. 1, 2012 in the journal Biological Psychiatry.
AZD6765, like ketamine, works by blocking glutamate binding to a protein on the surface of neurons, called the NMDA receptor. It is a less powerful blocker of the NMDA receptor, which may be a reason why it is better tolerated than ketamine.
About 32 percent of 22 treatment-resistant depressed patients infused with ASD6765 showed a clinically meaningful antidepressant response at 80 minutes after infusion that lasted for about half an hour – with residual antidepressant effects lasting two days for some. By contrast, 52 percent of patients receiving ketamine show a comparable response, with effects still detectable at seven days. So a single infusion of ketamine produces more robust and sustained improvement, but most patients continue to experience some symptoms with both drugs.
However, depression rating scores were significantly better among patients who received AZD6765 than in those who received placebos. The researchers deemed this noteworthy, since, on average, these patients had failed to improve in seven past antidepressant trials, and nearly half failed to respond to electroconvulsive therapy (ECT).
The patients reported only minor side effects, such as dizziness and nausea, which were not significantly different from those experienced with the placebo.
Zarate and colleagues say their results warrant further trials with AZD6765, testing whether repeated infusions a few times per week or higher doses might produce longer-lasting results.
###
Project number: 1ZIAMH002828-10
Clinical trial number: NCT00986479
Reference:
A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression. Zarate CA Jr, Mathews D, Ibrahim L, Chaves JF, Marquardt C, Ukoh I, Jolkovsky L, Brutsche NE, Smith MA, Luckenbaugh DA. Biol Psychiatry. 2012 Nov 30. doi:pii: S0006-3223(12)00941-9. 10.1016/j.biopsych.2012.10.019. [Epub ahead of print] PMID:
23206319
The mission of the NIMH is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery and cure. For more information, visit http://www.nimh.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
END
COLUMBUS, Ohio – A new study of the batteries commonly used in hybrid and electric-only cars has revealed an unexpected factor that could limit the performance of batteries currently on the road.
Researchers led by Ohio State University engineers examined used car batteries and discovered that over time lithium accumulates beyond the battery electrodes – in the "current collector," a sheet of copper which facilitates electron transfer between the electrodes and the car's electrical system.
This knowledge could aid in improving design and performance of batteries, explained ...
The date 12-12-12 may be numerically significant, but for the residents of American Samoa and Fiji in the South Pacific Ocean, it means a newborn tropical storm named Evan is causing problems. NASA's Aqua satellite and NOAA's GOES-15 satellite both captured imagery of the newborn storm's cloud cover.
Tropical Storm Evan caused regional warnings to be posted on Dec. 12. In American Samoa, a gale warning and storm watch are in effect for Tutuila, Aunuu, Manua and Swains Island.
The Atmospheric Infrared Sounder (AIRS) instrument aboard NASA's Aqua satellite captured an ...
DEERFIELD, Il. (December 11, 2012)—Inexpensive, locally-produced ceramic cookstoves may produce less smoke than traditional indoor 3-stone firepits, but they don't significantly reduce indoor air pollution or the risk of pneumonia in young children, according to results from a small, year-long observational study by researchers working in rural Kenya.
The findings, published online today in the American Journal of Tropical Medicine and Hygiene, are the first to examine the health impacts of ceramic cookstoves that do not vent smoke to the outside of the house, said Robert ...
An international collaboration including researchers from Lawrence Livermore National Laboratory has refined a key process in understanding extreme plasmas such as those found in the sun, stars, at the rims of black holes and galaxy clusters.
In short, the team identified a new solution to an astrophysical phenomenon through a series of laser experiments.
In the new research, appearing in the Dec. 13 edition of the journal Nature, scientists looked at highly charged iron using the Linac Coherent Light Source (LCLS) free-electron laser. Highly charged iron produces ...
TEMPE, Ariz. – One of the great mysteries of life is how it began. What physical process transformed a nonliving mix of chemicals into something as complex as a living cell?
For more than a century, scientists have struggled to reconstruct the key first steps on the road to life. Until recently, their focus has been trained on how the simple building blocks of life might have been synthesized on the early Earth, or perhaps in space. But because it happened so long ago, all chemical traces have long been obliterated, leaving plenty of scope for speculation and disagreement.
Now, ...
Are you allergic to peanuts and worried there might be some in that cookie? Now you can find out using a rather unlikely source: your cell phone.
A team of researchers from the UCLA Henry Samueli School of Engineering and Applied Science has developed a lightweight device called the iTube, which attaches to a common cell phone to detect allergens in food samples. The iTube attachment uses the cell phone's built-in camera, along with an accompanying smart-phone application that runs a test with the same high level of sensitivity a laboratory would.
Food allergies are ...
[EMBARGOED FOR DEC. 13, 2012] A new study suggests that human papillomavirus (HPV) infection in women at or after menopause may represent an infection acquired years ago, and that HPV infections may exist below limits of detection after one to two years, similar to other viruses, such as varicella zoster, which can cause shingles. The study, published in The Journal of Infectious Diseases and available online, highlights the need for additional research to better understand HPV infections and the role of HPV persistence and reactivation, particularly in women of the baby ...
An international team of scientists studying the elusive nocturnal primate the slow loris in the jungles of Borneo have discovered an entirely new species. The team's analysis of the primate's distinctive facial fur markings, published in the American Journal of Primatology, reveals the existence of one entirely new species, while two of species, previously considered as possible sub-species, are being officially recognized as unique.
"Technological advances have improved our knowledge about the diversity of several nocturnal mammals," said Rachel Munds from the University ...
WINSTON-SALEM, N.C., – Dec. 13, 2012 – Investigators at Wake Forest Baptist Medical Center have concluded research on a new postmenopausal hormone therapy that shows promise as an effective treatment for menopausal symptoms and the prevention of osteoporosis without increasing the risk for heart disease or breast cancer.
Traditional forms of hormone therapy (HT) provide the benefits of symptom relief, prevention of osteoporosis and prevention of atherosclerosis, but increase the risk of uterine cancer (with estrogens alone) or breast cancer (with combined estrogens and ...
CHESTNUT HILL, MA (Dec. 13, 2012) – A chemical nanostructure developed by Boston College researchers behaves much like the pores of the skin, serving as a precise control for a typically stubborn method of catalysis that is the workhorse of industrial chemistry.
Scientists have been trying to develop so-called yolk-shell catalysts as a means of imparting greater selectivity on heterogeneous catalysis, a process used in most industrial chemistry, including the manufacture of fine chemicals, petrochemicals and agrochemicals.
Boston College Assistant Professor of Chemistry ...
